Tavio Capital LLC - Q1 2018 holdings

$212 Million is the total value of Tavio Capital LLC's 12 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 166.7% .

 Value Shares↓ Weighting
ANTM BuyANTHEM INC$39,066,000
+29.0%
177,813
+32.1%
18.42%
+11.5%
CVS BuyCVS HEALTH CORP$24,588,000
+0.5%
395,240
+17.1%
11.60%
-13.2%
HUM NewHUMANA INC$17,608,00065,497
+100.0%
8.30%
CAH NewCARDINAL HEALTH INC$15,140,000241,546
+100.0%
7.14%
DVA BuyDAVITA INC$14,096,000
-6.7%
213,772
+2.2%
6.65%
-19.4%
ALXN NewALEXION PHARMACEUTICALS INC$13,229,000118,689
+100.0%
6.24%
HCA NewHCA HEALTHCARE INC$12,604,000129,933
+100.0%
5.94%
HRTX NewHERON THERAPEUTICS INC$9,708,000351,729
+100.0%
4.58%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC13Q2 202029.6%
CENTENE CORP DEL11Q2 202019.1%
ANTHEM INC10Q2 201922.5%
BOSTON SCIENTIFIC CORP9Q4 201920.9%
RETROPHIN INC9Q1 20193.4%
ZIMMER BIOMET HOLDINGS INC8Q2 202020.6%
HUMANA INC8Q4 201937.8%
UNIVERSAL HLTH SVCS INC8Q1 201914.7%
HCA HEALTHCARE INC8Q1 202012.3%
MCKESSON CORP7Q2 202023.1%

View Tavio Capital LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2020-10-01
13F-HR2020-08-13
13F-HR2020-05-14
13F-HR2020-02-13
13F-HR2019-11-13
13F-HR2019-08-13
13F-HR2019-05-14
13F-HR2019-02-14
13F-HR2018-11-13
13F-HR2018-08-13

View Tavio Capital LLC's complete filings history.

Compare quarters

Export Tavio Capital LLC's holdings